Chan et al. found RASSF1A gene hypermethylation in 93% of serum samples from patients with HCC and HBV and in 58% of blood samples from patients chronically infected with HBV, indicating that RASSF1A might be an early event in the pathogenesis of HCC [26]. This evidence concerns the gene RASSF1 and hepatocellular carcinoma.